Skip to content
GLSIGreenwich LifeSciences, Inc.

Earnings

When Greenwich LifeSciences, Inc. reports, what it reported each quarter, and how the stock took the results.

31 quarters. Mar 31, 2019 to Sep 30, 2026. mixed units.

Next results · Q4 2026Projected

10-K due Mar 29 – Apr 19

No earnings release is on file for this company, so the day is the 10-K’s, projected from its last 6 filings.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Mar 29 – Apr 19

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
—
Net income
-$9.15M
Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
EPS
—
EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m

Quarter by quarter

Q3 2026-$5.81MNo Q3 2025 on file

Latest results

  1. Q3 2026Nov 16, 2026, after the close
    Revenue
    —
    —
    Net income
    -$5.81M
    N/M
    EPS
    -$0.40
    N/M
  2. Q2 2026Aug 11, 2026, after the close+8.8%by the close of Aug 12
    Revenue
    —
    —
    Net income
    -$3.95M
    N/M
    EPS
    -$0.27
    N/M
  3. Q1 2026Jun 3, 2026, after the close2.6%by the close of Jun 4
    Revenue
    —
    —
    Net income
    -$5.66M
    N/M
    EPS
    -$0.39
    N/M
  4. Q4 2025Jun 1, 2026, after the close14.8%by the close of Jun 2
    Revenue
    —
    —
    Net income
    -$9.15M
    N/M
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026—Nov 16, 202647 d10-Q——-$0.40—
Q2 2026Jun 30, 2026—Aug 11, 202642 d10-Q——-$0.27+8.8%
Q1 2026Mar 31, 2026—Jun 4, 202665 d10-Q——-$0.392.6%
FY 2025
Q4 2025derivedDec 31, 2025—Jun 1, 2026152 d10-K———14.8%
Q3 2025Sep 30, 2025—Nov 14, 202545 d10-Q——-$0.271.1%
Q2 2025Jun 30, 2025—Aug 14, 202545 d10-Q——-$0.28+0.4%
Q1 2025Mar 31, 2025—May 20, 202550 d10-Q——-$0.215.5%
FY 2024
Q4 2024derivedDec 31, 2024—Apr 15, 2025105 d10-K———1.2%
Q3 2024Sep 30, 2024—Nov 14, 202445 d10-Q——-$0.200.5%
Q2 2024Jun 30, 2024—Aug 14, 202445 d10-Q——-$0.20+3.8%
Q1 2024Mar 31, 2024—May 20, 202450 d10-Q——-$0.19+3.5%
Earlier years, FY 2019 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 16, 2026052438
10-QAug 11, 2026037147
10-QJun 4, 2026027150
10-KJun 1, 2026026651
10-QNov 14, 2025023539
10-QAug 14, 2025024066
10-QMay 20, 2025011731
10-KApr 15, 2025004819
10-QNov 14, 2024045938
10-QAug 14, 2024032278

Provenance

ProvenanceData status and checks

Greenwich LifeSciences, Inc. · CIK 1799788 · Engraved from SEC EDGAR